In the pathogenesis of pulmonary hypertension, the main abnormalities are connected with mutations altering the properties of ALK1 and ALK5, BMPR2 and endoglin receptors, and SMAD8 signalling proteins (they are responsible for inhibiting signalling by R-SMAD) [7–10]. The gene discussed is ALK; the disease is pulmonary hypertension.